DoW Prostate Cancer, Idea Development Award

The fiscal year 2026 (FY26) Prostate Cancer Research Program (PCRP) Idea Development Award (IDA) supports new ideas that represent innovative approaches to prostate cancer research and have the potential to make an important contribution to the PCRP mission. All applications must address one of the FY26 PCRP Overarching Challenges, which include improving overall health, wellness, and survivorship for those impacted by prostate cancer, developing new treatments or improving existing therapies to improve outcomes for patients with lethal prostate cancer, enhancing clinical care for all patients with prostate cancer, and defining the biology of prostate cancer progression to lethal prostate cancer. • The funding opportunity is open to extramural and intramural U.S. Department of War (DOW) organizations, including foreign and domestic organizations, for-profit and nonprofit organizations, and public or private entities. • The application process involves a two-step submission, with a pre-application due on August 12, 2026, and a full application due on September 2, 2026. • The maximum period of performance is 3 years for Established Investigators and 4 years for New Investigators, with total cost caps of $1.7M and $2.1M, respectively. • The award will be granted as a grant, with an estimated total funding of $13.6M for Established Investigators and $21M for New Investigators.